LIFE INSURA CORP OF INDIA vs Roselabs Finance Ltd

A side-by-side comparison of LIFE INSURA CORP OF INDIA (LICI) and Roselabs Finance Ltd (ROSELABS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, LIFE INSURA CORP OF INDIA leads LICI vs ROSELABS on 9 of 14 metrics (3 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth· not comparable
  • Size & financial health30

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

9.14
P/E ratio
0.00
3.09
P/B ratio
-4.41
2.42%
Dividend yield
0.00%
₹45.42
EPS
₹-0.29

Profitability

LICI takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

37.80%
Return on equity
6.10%
35.00%
Return on capital
0.00%
5.00%
EBITDA margin
-43.66%
5.88%
Net margin
-40.85%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

7.61%
Revenue CAGR (3Y) even
16.86%
Profit CAGR (3Y) even

Size & financial health

LICI takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹5.16L Cr
Market cap
₹23 Cr
₹9.78L Cr
Revenue
₹1 Cr
₹57,453 Cr
Net profit
₹-0 Cr
0.00
Debt / equity even
0.00
LIFE INSURA CORP OF INDIA
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 45.6%"]
  • ["The company has delivered a poor sales growth of 7.19% over past five years."]
Roselabs Finance Ltd
  • ["Company has low interest coverage ratio."]
LIFE INSURA CORP OF INDIA full analysis Roselabs Finance Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

LICI vs ROSELABS: Share Price, Valuation & Which to Buy | DocStoX